These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25207692)

  • 21. [Systemic sensitization to 17-beta estradiol induced by transcutaneous administration].
    El Sayed F; Bayle-Lebey P; Marguery MC; Bazex J
    Ann Dermatol Venereol; 1996; 123(1):26-8. PubMed ID: 8734113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allergy and topical irritation associated with transdermal testosterone administration: a comparison of scrotal and nonscrotal transdermal systems.
    Jordan WP
    Am J Contact Dermat; 1997 Jun; 8(2):108-13. PubMed ID: 9153333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coagulation and fibrynolitic parameters in women and the effects of hormone therapy; comparison of transdermal and oral administration.
    Połać I; Borowiecka M; Wilamowska A; Nowak P
    Gynecol Endocrinol; 2013 Feb; 29(2):165-8. PubMed ID: 23116237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Addendum: Transdermal estrogen (Med Lett Drugs Ther 2012;54:41).
    Med Lett Drugs Ther; 2012 Jul; 54(1394):56. PubMed ID: 22826825
    [No Abstract]   [Full Text] [Related]  

  • 25. Editor's Comment--How Dangerous is Testosterone Supplementation?
    Jenkins LC; Mulhall JP
    Int Braz J Urol; 2015; 41(2):195-8. PubMed ID: 26005958
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical inquiries. How should we monitor men receiving testosterone replacement therapy?
    Alsina M; St Anna L
    J Fam Pract; 2010 Dec; 59(12):711-2. PubMed ID: 21135929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormone replacement therapy after endometrial cancer.
    Manley K; Edey K; Braybrooke J; Murdoch J
    Menopause Int; 2012 Dec; 18(4):134-8. PubMed ID: 23146818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Testosterone therapy: has overuse undermined use?
    The Lancet Diabetes Endocrinology
    Lancet Diabetes Endocrinol; 2018 Mar; 6(3):157. PubMed ID: 29475492
    [No Abstract]   [Full Text] [Related]  

  • 29. Estradiol associated with lower thrombotic risk than conjugated equine estrogens when used as oral HRT.
    Brown S
    Menopause Int; 2013 Dec; 19(4):145. PubMed ID: 24479171
    [No Abstract]   [Full Text] [Related]  

  • 30. Re: Use of testosterone replacement therapy in the United States and its effect on subsequent prostate cancer outcomes.
    Taneja SS
    J Urol; 2013 Oct; 190(4):1246. PubMed ID: 24029310
    [No Abstract]   [Full Text] [Related]  

  • 31. Exploring the hormone replacement therapy debate.
    Garad R; Burger H; Davison S
    Aust Nurs J; 2011 Nov; 19(5):30-3. PubMed ID: 22191153
    [No Abstract]   [Full Text] [Related]  

  • 32. Thrombotic thrombocytopenic purpura and 17 beta-estradiol transdermal skin patch.
    Liang R; Wong RW; Cheng IK
    Am J Hematol; 1996 Aug; 52(4):334-5. PubMed ID: 8701965
    [No Abstract]   [Full Text] [Related]  

  • 33. Hormone replacement therapy in menopause and lung cancer: an update.
    La Vecchia C
    Eur J Cancer Prev; 2006 Jun; 15(3):189-90. PubMed ID: 16679859
    [No Abstract]   [Full Text] [Related]  

  • 34. Breast cancer risk in postmenopausal women using estrogen-only therapy.
    Lyytinen H; Pukkala E; Ylikorkala O
    Obstet Gynecol; 2006 Dec; 108(6):1354-60. PubMed ID: 17138766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transdermal menopausal hormone therapy: delivery through skin changes the rules.
    Buster JE
    Expert Opin Pharmacother; 2010 Jun; 11(9):1489-99. PubMed ID: 20426703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secondary exposure to testosterone from patients receiving replacement therapy with transdermal testosterone gels.
    Miller MG; Rogol AD; Zumbrunnen TL
    Curr Med Res Opin; 2012 Feb; 28(2):267-9. PubMed ID: 22185432
    [No Abstract]   [Full Text] [Related]  

  • 37. The truth about testosterone replacement therapy. Fountain of youth--or harbinger of health woes?
    Johns Hopkins Med Lett Health After 50; 2014 Jun; 29(5):1-2. PubMed ID: 25097952
    [No Abstract]   [Full Text] [Related]  

  • 38. Implanted estrogen pellets associated with hypertriglyceridemia, biliary dyskinesia and focal nodular hyperplasia of the liver: a case report.
    Forman EJ; Guyton JR; Filip SJ; Price TM
    J Reprod Med; 2010; 55(1-2):87-90. PubMed ID: 20337216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostate cancer risk in testosterone-treated men.
    Raynaud JP
    J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):261-6. PubMed ID: 17113983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is testosterone therapy safe? Take a breath before you take the plunge. Understand the potential risks and consider alternatives before boosting your hormones indefinitely.
    Harv Mens Health Watch; 2014 Feb; 18(7):1, 7. PubMed ID: 24818282
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.